A group of medical doctors has uncovered evidence linking Pfizer’s Covid mRNA “vaccine” to a surge in deadly autoimmune diseases.
The link was uncovered during a study led by physician-scientist Dr. Ashraf Ullah, the head of Internal Medicine at May Hospital Lahore, Pakistan.
Dr. Ullah and his team conducted a case report involving a 40-year-old patient experiencing a Covid mRNA vaccine-linked injury involving Aplastic Anemia (AA) and Guillain-Barre Syndrome (GBS).
Specifically, the patient was vaccinated with the Pfizer-BioNTech BNT162b2 mRNA “vaccine.”
Shortly after receiving the injection, the patient experienced continuous vomiting, epistaxis, and other related symptoms.
Conducting bone marrow samples and diagnostic studies both indicated severe aplastic anemia.
The once-rare serious blood disorder occurs when the body’s bone marrow is unable to produce enough blood cells.
Concurrently, the patient was diagnosed with the onset of a GBS variation known as Acute Motor Sensory Axonal Neuropathy (AMSAN).
This condition typically involves an acute weakness in the limbs, respiratory failure, cranial nerve disorders, and sensory disturbances.
The doctors determined that the injuries were caused by the Covid mRNA shot.
They also noted that, after thorough investigations, there was a complete lack of any other possible cause.
Dr. Ullah and colleagues highlight the significance of monitoring and reporting to better understand the correlations between uncommon adverse events following Covid “vaccines” and autoimmune illnesses.
The doctors are calling for further investigation to examine these connections on a bigger scale and assess risk factors.
The unfortunate journey of the 40-year-old patient cited in the case study started 18 days after receiving a “booster” dose of Pfizer’s BNT162b2 mRNA injection.
After receiving the shot, he started suffering episodes of vomiting, each of which was immediately followed by spontaneous nosebleeds.
While “the nosebleed resolved spontaneously with pressure application,” four actual episodes occurred prior to the visit to the hospital’s outpatient department.
The authors of this case report note:
“During the general physical examination, signs indicative of anemia were observed in the patient.
“No remarkable findings were noted in the gastrointestinal system, and the initial assessments of the respiratory and cardiovascular systems were unremarkable.
“Initial investigations showed abnormal results on complete blood count, including a white cell count of 1.4×103 /µL, platelet count of 15×103 /µL, and hemoglobin level of 10.5 g/dL.”
Initiating a pancytopenia workup the attending providers conducted serological tests for hepatitis B, hepatitis C, and Human Immunodeficiency Virus (HIV), all turned up negative.
They then performed tests for Epstein-Barr Virus (EBV), Cytomegalovirus (CMV), and dengue virus, which also were negative.
With vitamin B12 and folic acid levels in the normal range (910 pg/ml and 7.6 ng/ml, respectively), other tests were done from complete blood count with peripheral smear and liver Function Tests (LFTs).
Renal Function Tests (RFTs) with all results are presented in a table in the journal entry.
The Pakistani doctors revealed they conducted a bone marrow biopsy which confirmed the aplastic anemia diagnosis.
The doctors report using “supportive measures, blood transfusions, immunosuppressants, and stimulating factors.
“For the GBS, the patient was promptly transferred to the Intensive Care Unit (ICU). Fortunately, mechanical ventilation was not required, and Intravenous Immunoglobulins (IVIG) at a dose of 0.4 g/kg daily for 5 days were initiated.”
Luckily, the patient responded well, evidencing significant improvement.
However, the patient disappeared and never returned for further checkups.
The doctors revealed that it’s not known how the patient is doing.
